share_log

Ladenburg Thalmann Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $3

Ladenburg Thalmann Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $3

Ladenburg Thalmann 以買入評級開始對Coeptis Therapeutics進行報道,宣佈目標股價爲3美元
Benzinga ·  2023/09/22 07:49

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and announces Price Target of $3.

拉登堡·塔爾曼分析師Aydin Huseynov以買入評級啟動對Coeptis治療公司(納斯達克:COEP)的報道,並宣佈目標價為3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論